Crossmark

An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s disease

Published Online: 2016-01-28

Published Print: 2016-12

Authors

Elkahloun, Abdel G.

Hafko, Roman

Saavedra, Juan M.
Funding

Funding for this research was provided by:

National Institutes of Health
License Information

Text and Data Mining valid from 2016-01-28

Version of Record valid from 2016-01-28
More Information

Article History

Received: 26 September 2015

Accepted: 8 December 2015

First Online: 28 January 2016

Document is current